RPRX stock

Royalty Pharma Plc (RPRX) valuation · P/E 33, rev $2.38B

Royalty Pharma Plc (RPRX) P/E 33, rev $2.38B.

Cached valuation scalars
MetricValue
P/E33
Market cap$20.45B
Revenue$2.38B
P/S8.6
Dividend yield2.44%
These valuation metrics as JSON? API free 100/day

RPRX valuation FAQ

What is RPRX's P/E ratio?

Royalty Pharma Plc (RPRX) trailing P/E is 33 on the latest cached fundamentals snapshot.

What is RPRX's market cap?

Royalty Pharma Plc (RPRX) market cap is $20.45B on the latest cached fundamentals snapshot.

What is RPRX's latest revenue?

Latest cached Royalty Pharma Plc (RPRX) revenue was $2.38B. Statements: https://lician.com/financials/rprx

What is RPRX's price-to-sales ratio?

Royalty Pharma Plc (RPRX) price-to-sales (P/S) is 8.6, cached market cap $20.45B divided by revenue $2.38B.

What is RPRX's dividend yield?

Royalty Pharma Plc (RPRX) dividend yield is 2.44% on the latest cached fundamentals snapshot.

How many RPRX valuation scalars are listed on this page?

This page lists 5 cached valuation scalars for Royalty Pharma Plc (RPRX): P/E, Market cap, Revenue, P/S, and Dividend yield.

Where is RPRX valuation listed?

Cached valuation multiples for Royalty Pharma Plc (RPRX) are listed at https://lician.com/valuation/rprx.

Not investment advice. Cached rows, not a live tape.